Fellowship · ATLANTA, GA
Sponsored by Emory University School of Medicine
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.
Nature · 2021 · 1,859 citations · Vivien Sheehan
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
The New England journal of medicine · 2023 · 550 citations · Leslie Kean
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children.
The New England journal of medicine · 2025 · 187 citations · Tamara Miller
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.
Blood advances · 2021 · 446 citations · Robert Sidonio
Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes.
The New England journal of medicine · 2025 · 119 citations · Leslie Kean
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 202 citations · Edmund Waller
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 326 citations · Muna Qayed
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
The Lancet. Oncology · 2021 · 515 citations · Edmund Waller